- $163.28m
- $722.35m
- $50.25m
- 25
- 94
- 45
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 124 | 100 | 95.6 | 70.3 | 50.2 |
Cost of Revenue | |||||
Gross Profit | 46.1 | 32.8 | 39.3 | 8.37 | -27.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 87.2 | 67 | 53.6 | 82.4 | 97 |
Operating Profit | 37.2 | 33.5 | 42 | -12.1 | -46.7 |
Net Income Before Taxes | 37.2 | 33.5 | 42 | -12.1 | -46.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 37.1 | 33.6 | 41.8 | -14.9 | -47 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 34.7 | 28.5 | 41.9 | -15 | -47.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 34.4 | 22.6 | 33.8 | -28.3 | -48.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.24 | 1.03 | 1.14 | -0.918 | -2.01 |
Dividends per Share | |||||
Special Dividends per Share |